Our data provide evidence that Th17‐instructed cervical cancer cells showed reduced responsiveness toward chemotherapeutic drug, irradiation, and combined treatment and identified Th17‐induced activation of the AKT signaling pathway as the responsible resistance mechanism. The gene discussed is AKT1; the disease is cervical cancer.